Paul Edwards, Financial Director, bought 45,364 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds 94,864...

Lothan Mentel, Executive Director, bought 25,797 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds 991,785...

Chris Poil, Non Executive Director, bought 45,000 shares in the company on the 11th November 2019 at a price of 220.44p. The Director now holds...

Bill Floydd, Executive Director, bought 25,000 shares in the company on the 11th November 2019 at a price of 215.75p. The Director now holds 25,000...

Helen Bunch, Non Executive Director, bought 1,103 shares in the company on the 11th November 2019 at a price of 269.14p. The Director now holds...

Simon Hayes, Non Executive Director, has re-invested 328 shares in the company on the 8th November 2019 at a price of 888.20p. The Director now...

Caner and neurological-condition focused Evgen Pharma said a trial of a treatment for subarachnoid haemorrhage, a type of stroke, had failed to achieve its primary...

Events group Arena Events said it had agreed to a new £2m debt facility, having recently been awarded a number of new contracts across its...

InfraStrata said it would raise £6.0m from a share issue to fund the acquisition of troubled Irish shipyard Harland & Wolff from administrators.

New shares...

Cyber security and intelligence services provider Falanx said its revenue had grown by about 20% in the first half of its financial year.

In a...